Worldwide Recall On Allergan Textured Breast Implants

Allergan PLC announced that it would take its Biocell textured breast implants and tissue expanders off the market worldwide shortly after the US FDA released additional information linking the use of the implants to a rare cancer.

Implant

Device manufacturer Allergan PLC announced a worldwide recall of its Biocell textured breast implants and tissue expanders Wednesday morning, shortly after the US Food and Drug Administration released a safety communication citing additional data linking the implants with a rare form of cancer.

The breast implants and tissue expanders have been tied to breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a relatively rare...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Recalls

More from Policy & Regulation